Search
for
Sort by
Research 121–150 of 1000+
- An Overview about Alopecia Areata Etiopathogenesis, Diagnosis, and Management: Review Article
- 056 IKZF1 and IKAROS overexpression contributes to the pathogenesis of alopecia areata
- Rare Presentation of Concomitant Alopecia Areata and Vitiligo in a Teenager
- 218 Chemokine receptor CCR5 is the novel target for the treatment of alopecia areata
- 046 Analysing the mechanistic basis of Ritlecitinib’s therapeutic effects in Alopecia Areata
- The role of lymphocytes in the development and treatment of alopecia areata
- Th1 Chemokine CXCL10 and Alopecia Areata: The Possible Target for the Treatment of Alopecia Areata
- Hepatitis C‐related mixed type vitiligo in a patient with Ivemark syndrome
- LB881 Unraveling mechanisms of scarring alopecia in discoid lupus: Insights from spatial transcriptomics
- 1406 Environmental pathobiology of frontal fibrosing alopecia (FFA): A link between linalool sensitization and FFA development
- 080 Mouse models of alopecia areata: C3H/HeJ mice versus the humanized AA mouse model
- 0977 Pathogenic hallmarks of primary lymphocyte-mediated scarring alopecia revealed by single nuclear and spatial multiomics
- 178 Neutrophil elastase is critical in linear IgA bullous dermatosis in mice
- 175 Understanding immune privilege in an inducible mouse model of primary cicatrcial alopecia
- Alopecia Areata
- Alopecia areata
- Alopecia Areata in Aging C3H/HeJ Mice
- The autoimmune basis of alopecia areata: A comprehensive review
- Autoimmunity: Alopecia Areata
- Hair follicle immune privilege and its collapse in alopecia areata
- Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies
- The Role of Hair Follicle Immune Privilege Collapse in Alopecia Areata: Status and Perspectives
- Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease‐associated psychological morbidity
- Frontiers in alopecia areata pathobiology research
- The PDE4 inhibitor, apremilast, suppresses experimentally induced alopecia areata in human skin in vivo
- Deciphering the Complex Immunopathogenesis of Alopecia Areata
- Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
- A transcriptomic map of murine and human alopecia areata
- Serum granulysin as a possible key marker of the activity of alopecia areata
- Frontal Fibrosing Alopecia: A Review